This information is for residents of Australia.

mRESVIA®

mRESVIA is a vaccine indicated for:

active immunisation for the prevention of lower respiratory tract disease (LRTD) and acute respiratory disease (ARD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older.

PRODUCT INFORMATION

CONSUMER MEDICINE INFORMATION

How can we help you?

Report a side effect

Online: Moderna's Adverse Event Intake Portal

Connect with us

Email: WeCare@modernatx.com 
Call: 1800 344 018 Monday - Friday 8:30 AM to 7:00 PM AEST (closed holidays)